PPP2R5D and Parkinson disease: These early-onset Parkinson’s disease (EOPD) phenotypes were responsive to levodopa treatments.10-12 Apart from the known role of PPP2R5D in dopamine synthesis and neurotransmission, how PPP2R5D variants contribute to disease at a molecular and cellular level is unclear.13-15